Operating Income (Loss) in USD of Scinai Immunotherapeutics Ltd. from 2021 to 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Scinai Immunotherapeutics Ltd. quarterly and annual Operating Income (Loss) history and change rate from 2021 to 2024.
Scinai Immunotherapeutics Ltd. Operating Income (Loss) for the quarter ending 30 Jun 2023 was $-2,595,000, a 20.5% increase year-over-year.
Scinai Immunotherapeutics Ltd. annual Operating Income (Loss) for 2024 was $-8,638,000, a 11% increase from 2023.
Scinai Immunotherapeutics Ltd. annual Operating Income (Loss) for 2023 was $-9,706,000, a 12.3% increase from 2022.
Scinai Immunotherapeutics Ltd. annual Operating Income (Loss) for 2022 was $-11,061,000, a 1.83% decline from 2021.

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Change (%)

Operating Income (Loss), Annual (USD)

Operating Income (Loss), YoY Annual Change (%)

Scinai Immunotherapeutics Ltd. Quarterly Operating Income (Loss) (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2023	$-2,595,000	+$668,000	+20%	01 Apr 2023	30 Jun 2023	6-K/A	18 Aug 2023	2023	Q2
Q1 2023	$-3,186,000	-$571,000	-22%	01 Jan 2023	31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q2 2022	$-3,263,000			01 Apr 2022	30 Jun 2022	6-K/A	18 Aug 2023	2023	Q2
Q1 2022	$-2,615,000			01 Jan 2022	31 Mar 2022	10-Q	15 May 2023	2023	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$-8,638,000	+$1,068,000	+11%	01 Jan 2024	31 Dec 2024	20-F	07 May 2025	2024	FY
2023	$-9,706,000	+$1,355,000	+12%	01 Jan 2023	31 Dec 2023	20-F	07 May 2025	2024	FY
2022	$-11,061,000	-$199,000	-1.8%	01 Jan 2022	31 Dec 2022	20-F	07 May 2025	2024	FY
2021	$-10,862,000			01 Jan 2021	31 Dec 2021	10-K	17 Apr 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.